Notes
MORNING BID
🔸 Nvidia ( $NVDA):
• Q4 adj. EPS $0.89 (est. $0.84)
• revs $39.33B (est. $38.05B)
• Data center revs $35.6B (+93%)
• Auto $570M (+103%)
• Gaming $2.5B (-11%)
• Q1 revs $43B ±2% (est. $41.78B).
🔸 Amazon ( $AMZN): Debuted Ocelot, its first quantum computing chip.
🔸 Snowflake ( $SNOW):
• Q4 EPS $0.30 (est. $0.18)
• revs $986.8M (+28%, est. $956.26M)
• Q1 product revs guidance $955M-$960M (est. $962.6M); expanded Microsoft partnership.
🔸 Salesforce ( $CRM)
• Q4 adj. EPS $2.78 (est. $2.61)
• revs $9.99B (missed est. $10.04B)
• Q1 guidance below consensus: EPS $2.53-$2.55, revs $9.71B-$9.76B.
🔸 https://t.co/dPTowbRrks ( $AI):
• Q3 EPS -$0.12 (est. -$0.25)
• revs $98.8M (+26%, est. $98.1M)
• Q4 revs guidance $103.6M-$113.6M (est. $108.6M).
🔸 Magnite ( $MGNI)
Q4 adj. EPS $0.34 (est. $0.36)
revs $194M (est. $184.3M)
FY adj. EBITDA guidance mid-teens % (est. +12.8%).
🔸 Nutanix ( $NTNX)
Q2 adj. EPS $0.56 (est. $0.47)
revs $654.7M (est. $641.86M)
Q3 revs guidance $620M-$630M (est. $594.39M).
🔸 eBay ( $EBAY)
Q4 adj. EPS $1.25 (est. $1.20)
revs $2.6B (est. $2.58B)
GMV $19.3B (+4%)
Q1 adj. EPS guidance $1.32-$1.36 (est. $1.33)
revs $2.52B-$2.56B (est. $2.59B)
GMV $18.3B-$18.6B.
🔸 Paramount ( $PARA): Q4 revs $7.98B (est. $8.1B); Paramount+ added 5.6M subs (est. 2.58M).
🔸 Pure Storage ( $PSTG): Q4 EPS $0.45 (est. $0.42), revs $879.8M (est. $869.19M); FY revs guidance $3.515B (est. $3.52B).
🔸 Synopsys ( $SNPS): Q1 EPS $3.03 (est. $2.79), revs $1.46B (est. $1.45B); FY EPS guidance $14.88-$14.96 (est. $14.89).
🔸 TaskUs ( $TASK): Q4 EPS $0.31 (est. $0.34), revs $274.2M (est. $268.8M); FY adj. EBITDA margin ~21%.
🔸 TKO Group ( $TKO): Q4 EPS $0.28 (est. $0.21), revs $642.2M (est. $604M); FY adj. EBITDA $1.35B-$1.39B (FY24: $1.25B).
🔸 Norwegian Cruise Line ( $NCLH): Q4 adj. EPS $0.26 (est. $0.11), revs $2.11B (in line); Q1 Net Yield expected to rise ~0.5% y/y (constant currency).
🔸 Urban Outfitters ( $URBN): Q4 adj. EPS $1.04 (est. $0.94), revs $1.64B (+10%, est. $1.61B); Retail segment sales +6.3%, driven by digital and store growth.
🔸 Agilent ( $A): Q1 adj. EPS $1.31 (est. $1.27), revs $1.68B (est. $1.67B); Q2 guidance below estimates; FY25 revs cut to $6.68B-$6.76B (est. $6.82B).
🔸 CareDx ( $CDNA): Q4 adj. EPS $0.18 (est. $0.15), revs $86.6M (est. $84.56M); FY25 revs guidance $365M-$375M (est. $370.02M); Testing services revs +37% y/y.
🔸 Catalyst Pharma ( $CPRX): Q4 EPS $0.70 (est. $0.55), revs $141.8M (+28%, est. $134.2M); FY revs guidance $545M-$565M (est. $558.1M).
🔸 Outset Medical ( $OM): Filed $100M mixed securities shelf.
🔸 Sarepta ( $SRPT): Q4 adj. EPS $1.90 (in line), revs $658.4M (est. $627.58M).
🔸 Teladoc ( $TDOC): Q4 EPS -$0.28 (est. -$0.24), revs $640.49M (est. $639.55M); FY revs and EBITDA guidance below estimates.
🔸 Tandem Diabetes ( $TNDM): Q4 EPS $0.01 (est. -$0.23), revs $282.6M (est. $251.98M); FY revs guidance $997M-$1.007B (est. $1.008B).
🔸 Universal Health ( $UHS): Q4 adj. EPS $4.92 (est. $4.18), revs $4.11B (est. $4.01B); FY revs and EBITDA guidance above estimates.
MORNING BID
🔸 $ACMR: Raises 2024 revenue forecast to $755M-$770M from $725M-$745M; sees 2025 at $850M-$950M vs. consensus $902.95M.
🔸 $APLD: Shares up 30% after Macquarie's $5B investment for 15% stake in AI data centers.
🔸 $AVGO: Secures $7.5B five-year credit facility.
🔸 $IAC: To spin off $ANGI stake to shareholders; Joey Levin steps down as CEO.
🔸 $TTAN: Q3 revenue $199.3M; Q4 expected at $199M-$201M vs. consensus $193.58M; FY25 revenue projected at $761.6M-$763.6M vs. consensus $755.37M.
🔸 $DHR: Q4 revenue expected to rise by low single digits year-over-year.
🔸 $INGN: Q4 revenue forecast at $79.0M-$80.0M, above $73.9M estimate; FY24 revenue guidance raised to $334.5M-$335.5M from $329M-$331M, vs. $329.62M consensus.
🔸 $KIDS: Q4 revenue at $52.7M vs. $50.73M estimate; FY25 revenue guidance $235-242M vs. $239.95M estimate, adjusted EBITDA $15-17M vs. $20.14M forecast.
🔸 $RGNX: Stock up after deal with Nippon Shinyaku for gene therapies; $110M upfront and potential $700M in milestones.
🔸 $TDOC: New partnership with $AMZN to broaden access to chronic care programs.
🔸 $RILY: Shares rise after Q2 2024 report showing a $14.35 per share net loss, delayed due to Franchise Group issues; expects normal filing schedule in 2025.
🔸 $AB: AUM fell to $792B in December 2024 from $813B, a 2.6% drop due to market and outflow issues.
🔸 $IVZ: AUM dropped to $1,846B, down 0.6% with $12.6B in net long-term inflows but $42B reduction from market returns.
🔸 $VRTS: Total client assets at $177.3B in December 2024, down due to outflows and market performance.
🔸 $URI: Acquiring $HEES for $92/share, valuing the deal at $4.8B including debt.
Insurance Industry: LA wildfires might cost insurers over $30B, with significant damage from Palisades and Eaton fires.
🔸 $AVAV: Secures $55.3M order for Switchblade Systems under U.S. Army's LUS program.
🔸 $CE: Upgraded to Buy from Underperform by Bank of America on valuation.
🔸 $FANG: Q4 unhedged prices at $69.48/bbl oil, $0.48/mcf gas, $19.27/bbl NGLs; hedged prices at $68.72/bbl oil, $0.82/mcf gas, $19.27/bbl NGLs.
🔸 $WAB: Agrees to purchase Evident's inspection tech division for $1.78B.
🔸 $KBH: Q4 EPS $2.52 vs. $2.45 est., revenue $1.999B vs. $2.008B est.; FY25 housing revenue guidance $7.00-7.50B, avg selling price $488-498K.
🔸 $NOMD: 2025 organic revenue growth expected at 1%-3%; confident in meeting 2024 guidance.
🔸 $SIG: Q4 adj. operating income forecast at $337M-$347M, below previous $397M-$427M; sales expected at $2.32B-$2.34B, under prior $2.38B-$2.46B.
🔸 $ADM: Downgraded to Underperform from Neutral by Bank America.
🔸 $LVS: Downgraded to Equal Weight from Overweight by Morgan Stanley.